Cingulate, Inc. (CING)
5.30
+0.11
(+2.12%)
USD |
NASDAQ |
Sep 09, 09:58
Cingulate Debt to Equity Ratio : 0.2681 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2681 |
| March 31, 2026 | 0.3938 |
| December 31, 2025 | 3.502 |
| September 30, 2025 | 1.318 |
| June 30, 2025 | 1.194 |
| March 31, 2025 | 0.8568 |
| December 31, 2024 | 0.6839 |
| September 30, 2024 | 0.0195 |
| June 30, 2024 | 0.1071 |
| Date | Value |
|---|---|
| March 31, 2024 | 0.1315 |
| December 31, 2023 | -0.511 |
| September 30, 2023 | -37.43 |
| June 30, 2023 | -1.426 |
| March 31, 2023 | 70.87 |
| December 31, 2022 | 1.511 |
| September 30, 2022 | 0.6717 |
| June 30, 2022 | 0.0584 |
| March 31, 2022 | 0.0498 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| ANI Pharmaceuticals, Inc. | 1.022 |
| Corcept Therapeutics, Inc. | 0.0133 |
| Veru, Inc. | 0.0945 |
| Johnson & Johnson | 0.5771 |
| Eli Lilly & Co. | 1.621 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 33.07M |
| Total Liabilities (Quarterly) | 9.599M |
| Shareholders Equity (Quarterly) | 23.47M |
| Current Ratio | 3.50 |
| Net Debt Paydown Yield | -0.32% |